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In principle, evolutionary outcomes could be largely predicted if all
of the relevant physicochemical variants of a particular protein
function under selection were known and integrated into an ap-
propriate physiological model. We have tested this principle by
generating a family of variants of the tetracycline resistance pro-
tein TetX2 and identiﬁed the physicochemical properties most cor-
related with organismal ﬁtness. Surprisingly, small changes in the
Km(MCN), less than twofold, were sufﬁcient to produce highly suc-
cessful adaptive mutants over clinically relevant drug concentra-
tions. We then built a quantitative model directly relating the in
vitro physicochemical properties of the mutant enzymes to the
growth rates of bacteria carrying a single chromosomal copy of
the tet(X2) variants over a wide range of minocycline (MCN) con-
centrations. Importantly, this model allows the prediction of enzy-
matic properties directly from cellular growth rates as well as the
physicochemical-ﬁtness landscape of TetX2. Using experimental
evolution and deep sequencing to monitor the allelic frequencies
of the seven most biochemically efﬁcient TetX2 mutants in 10 in-
dependently evolving populations, we showed that the model
correctly predicted the success of the two most beneﬁcial variants
tet(X2)T280A and tet(X2)N371I. The structure of the most efﬁcient
variant, TetX2T280A, in complex with MCN at 2.7 Å resolution sug-
gests an indirect effect on enzyme kinetics. Taken together, these
ﬁndings support an important role for readily accessible small
steps in protein evolution that can, in turn, greatly increase the
ﬁtness of an organism during natural selection.
experimental evolution | genome to phenome | oxidoreductase
What determines success or failure of variants within a pop-ulation undergoing selection? To answer this challenging
question, experimental evolution, genomics, and biochemistry
have proved to be powerful approaches to the formulation of
speciﬁc and testable hypotheses that can be validated in a quanti-
tative manner.Most recently, experimental evolution has provided
a wealth of insights into epistasis (1–3), adaptive convergence
among populations (4, 5), and the role of mutation supply (6, 7) in
asexual populations (8). Dean and Thornton coined the term
“functional synthesis” to encompass the increasingly relevant role
for molecular biology, biochemistry, and biophysics in elucidating
a strong quantitative link between changes in genomes (genotype)
to their resultant changes inmolecular properties (phenotype) and
ﬁtness, the property that selection acts upon (9). Dykhuizen and
coworkers were among the ﬁrst to recognize the importance of the
functional synthesis when they successfully modeled the adaptive
landscape of the lactose operon to quantitatively predict growth
rates (10). Whereas the qualitative link between an enzyme
function under selection and ﬁtness is typically straightforward, it
has proved very challenging to predict how speciﬁc adaptive
changes in readily measurable in vitro biophysical properties of
a protein can be used to make accurate predictions of growth rates
and evolutionary outcomes over a range of selective conditions. In
addition to physicochemical properties, interactions among dif-
ferent mutants in a population such as clonal interference, the
stochasticity with which newmutations arise, and the fact that even
beneﬁcial mutations can be lost through drift when they are very
rare affect evolutionary dynamics (11).
We tested two important principles that are the key to the
hypothesis that a careful physicochemical analysis of potential
adaptive mutants can be used to predict evolutionary dynamics
within large asexual populations undergoing selection (Fig. 1):
ﬁrst, that the physicochemical analysis of potential adaptive
mutants and the development of an appropriate physiological
model can quantitatively predict growth rates of bacteria carry-
ing these alleles over a broad range of selective conditions; and
second, that these ex vivo predictions for growth would predict
the evolutionary dynamics in a population undergoing selection.
To test these principles, we used in vitro error-prone muta-
genesis to identify adaptive mutants of Bacteroides thetaiotao-
micron TetX2 that conferred similar or increased resistance to
minocycline (MCN) within 1-nt change of the original sequence.
From the TetX2 library, seven potential adaptive mutants were
identiﬁed and characterized biochemically to determine their
steady-state enzyme kinetics. Each adaptive tet(X2) allele was
then introduced as a single chromosomal copy into the Escher-
ichia coli spc operon that encodes 10 ribosomal proteins, and
their growth rates were measured over a wide range of MCN
concentrations. Using data from a combination of the in vitro
kinetics and in vivo expression level measurements we were able
to build a mathematical model that accurately and quantitatively
predicted the bacterial growth rates from biochemical ﬁrst
principles such as kcat, Km(MCN), and Km(NADPH) and steady-state
expression levels. An unexpected ﬁnding from these studies was
the critical role of very small changes in physicochemical
parameters and their outsized effects on bacterial growth rates
over the relevant MCN selection range. For example, less than
a twofold change in Km and <20% change in kcat toward MCN
for the best adaptive mutant [tet(X2)T280A] increased growth rate
240% at 10 μg/mL MCN. After establishing the relationship
of biochemical parameters to growth kinetics of the seven most
successful adaptive TetX2 mutants, experimental evolution was
used tomonitor adaptation in 10 bacterial populations undergoing
selection to increasing amounts of MCN.
The broad success of the model in building a quantitative link
between enzyme function and growth rates suggests that, under
speciﬁc conditions, growth rates over a wide range of selective
conditions can provide a robust and high-throughput means of
estimating kinetic parameters for libraries of enzyme variants
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without arduous puriﬁcation of the individual protein variants.
This approach can further expand our understanding of protein
evolution and the physicochemical principles underlying natural
selection. Most importantly, these ﬁndings highlight the critical
relationship of small changes in enzyme performance to highly
relevant changes in organismal ﬁtness during natural selection.
Results
TetX2 Variants Expressed from the Chromosomal spc Operon of E. coli
Directly Drive Fitness to Minocycline. The success of cells with newly
acquired mutations in an evolving population depends strongly on
the ﬁtness beneﬁt conferred by the mutations under speciﬁc
conditions of selection. Elucidating a physicochemical basis for
evolutionary dynamics is made easier if relevant adaptive muta-
tions have been identiﬁed and characterized. In vitro error-prone
mutagenesis was used to identify potential single-point mutations
of tet(X2) that could be candidates for natural selection in a bac-
terial population undergoing adaptation to increasing MCN con-
centrations (Fig. S1). Seven adaptive mutants that conferred equal
or greater minimal inhibitory concentrations (MICs) to MCN than
wild type tet(X2) were identiﬁed from the library (Table 1).
As MCN concentrations are increased, the ability of a partic-
ular tet(X2) variant to reduce cytoplasmic MCN concentrations
to a point sufﬁcient to maintain wild-type growth rates becomes
increasingly difﬁcult until TetX2 is unable to maintain a sufﬁ-
ciently low steady-state concentration ofMCN, resulting in slower
growth rates. Here, we use absolute growth rate as a measure for
ﬁtness because it provides a more accurate link between physi-
cochemical properties of TetX2 and bacterial growth than MICs.
We introduced each of the adaptive tet(X2) alleles as a single
chromosomal copy into the spc operon ofE. coliBW25113 by Red
short-homology recombineering (12) and measured the growth
rates of E. coli BW25113 and the eight recombineered strains
over a range ofMCN concentrations that correspond to Food and
Drug Administration guidelines for the susceptibility testing of
Enterobacteria at 37 °C (13) (Fig. S2 and Table S1).
The growth rates of the wild-type tet(X2) and all of the tet(X2)
mutants were signiﬁcantly lower than the growth rates of the host
BW25113 without tet(X2), indicating a ﬁtness cost of 4.6% to
carrying a tet(X2) allele (planned comparison between host
without and strains with tet(X2) alleles: F1,23 = 25.9, P < 0.0001).
As expected, with increasing MCN concentration, the growth
rates of all tet(X2) mutants decreased (Fig. 2). Three mutants,
tet(X2)F235Y, tet(X2)S326I, and tet(X2)N371T, exhibited intermediate
ﬁtness compared with the most successful mutant, tet(X2)T280A. At
32 μM MCN, the breakpoint for clinical resistance, tet(X2)T280A
was 1.7, 1.6, and 1.2 times ﬁtter than tet(X2)F235Y, tet(X2)S326I, and
tet(X2)N371T, respectively. Tet(X2)N371I and tet(X2)T280A had the
Fig. 1. Predicting evolutionary outcomes using experimental evolution and biochemistry. (A) Changes in physicochemical properties of adaptive mutants
that correlate with changes in ﬁtness (growth rates) are determined and used to model the in vivo performance of the organisms expressing mutant alleles.
(B) The predictions based on the mathematical model are tested by monitoring allelic frequencies, using deep sequencing.
Table 1. Steady-state kinetic parameters for wild-type TetX2 and adaptive mutants
Km(MCN), μM Km(NADPH), μM kcat (Vmax/[Etotal]), s−1 kcat /Km(MCN), μM−1·s−1 kcat/Km(NADPH), μM−1·s−1 Δ growth rates at 32 μM MCN, %*
WT 35 ± 1.9 75 ± 4.1 0.34 ± 0.01 0.010 ± 0.0006 0.004 ± 0.0003 100
T280A 18 ± 0.9 18 ± 1.1 0.43 ± 0.01 0.024 ± 0.0013 0.024 ± 0.0016 540
N371I 18 ± 1.9 64 ± 6.3 0.37 ± 0.02 0.020 ± 0.0024 0.006 ± 0.0006 530
N371T 24 ± 2.1 130 ± 11 0.40 ± 0.02 0.017 ± 0.0017 0.003 ± 0.0003 440
S326I 37 ± 2.8 73 ± 5.5 0.36 ± 0.01 0.010 ± 0.0008 0.005 ± 0.0004 340
F235Y 54 ± 6.1 99 ± 11 0.32 ± 0.06 0.006 ± 0.0013 0.003 ± 0.0007 320
K64R 36 ± 4.6 110 ± 15 0.32 ± 0.03 0.009 ± 0.0014 0.003 ± 0.0005 86
T280S 30 ± 3.4 100 ± 14 0.18 ± 0.01 0.006 ± 0.0008 0.002 ± 0.0003 65
*Changes in growth rates of mutant alleles are relative to the wild-type tet(X2) growth rate set at 100%.
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fastest growth rates at intermediate and high MCN concen-
trations, suggesting that both mutants would have comparable
success in a population during selection at MCN concentrations
that would be used clinically (13).
Adaptive Mutations to TetX2 That Determine Evolutionary Dynamics
over a Clinically Relevant MCN Range Show Remarkably Small Changes
in Kinetic Performance. The in vivo resistance of bacteria expressing
each candidate tet(X2) mutant was directly linked to the in vitro
catalytic properties of TetX2 through steady-state activity assays
that measure the kinetics of MCN inactivation in vitro. The cat-
alytic proﬁles exhibited by TetX2 adaptive mutants suggest that
surprisingly small changes in TetX2 steady-state kinetic parame-
ters have large consequences on the in vivo performance of the
organisms in a population. TetX2 is a ﬂavin-dependent mono-
oxygenase that regioselectively hydroxylates tetracyclines in a re-
action that requires both NADPH and molecular oxygen (14). The
initial velocities of MCN inactivation were measured at various
NADPH and MCN concentrations (Table 1), and the steady-state
kinetic parameters [Km(MCN), Km(NADPH), and kcat] for each puri-
ﬁed mutant enzyme were determined. Overall, the adaptivemutants
exhibited similar mechanistic behaviors. As shown in Fig. 3A, the
initial velocities of the enzyme (here, TetX2T280A) at differentMCN
concentrations increased with increasing NADPH, which, in turn,
resulted in an increase in Vmax(obs). In addition, the Km(obs) also
increases with increasing NADPH concentrations, which suggests
that only binary complexes of the enzyme with these substrates can
occur and that MCN and NADPH cannot be bound simultaneously
in the active site (i.e., no ternary TetX2:MCN:NADPH complex
forms). Lineweaver–Burke plots of initial velocities vs. MCN
concentration strongly support a ping-pong mechanism for TetX2
inactivation of MCN (Fig. 3B). Therefore, the kinetic parameters
Km(MCN), Km(NADPH), and kcat (Vmax = kcat × [E], where E is total
enzyme concentration) reported in Table 1 were calculated by ﬁt-
ting initial velocities to a simple, rapid equilibrium ping-pong model
for the two substrates MCN and NADPH (Eq. S1 and Schemes S1
and S2) (15).
Surprisingly, the changes in Kms toward MCN and NADPH, as
well as kcat, that determined the growth rates within the individual
strains and their subsequent success or failure during experimental
evolution within populations are remarkably small (Table 1). The
most successful TetX2 mutant, TetX2T280A, had less than a twofold
decrease in Km (18 μM) for MCN and a fourfold decrease for
NADPH (18 μM) compared with the wild-type enzyme [Km(MCN) =
35 μM, Km(NADPH) = 75 μM]. All seven TetX2 mutants isolated
from in vitro mutagenesis had a measured kcat comparable to that
of wild-type TetX2 (kcat = 0.34 s
−1) and although TetXT280A had
the highest kcat (0.43 s
−1), the increase was quite modest (∼20%).
The efﬁciencies of the two catalytic steps, ﬁrst, FAD reduction by
NADPH and, second, hydroxylation of MCN, were altered by at
most ﬁvefold (TetX2T280A). TetX2K64R had no signiﬁcant change
in the Km(MCN) but a higher Km(NADPH) and no change in kcat, which
is largely consistent with its in vivo growth rates.
The subtle changes in kinetic parameters of the most successful
mutants TetX2T280A and TetX2N371I conferred a >500% ﬁtness
beneﬁt over that of the wild-type enzyme at 32 μM MCN (Fig. 2
and Table 1). However, the enzymatic proﬁles of TetX2S326I and
TetX2F235Y were very similar to those of the wild-type enzyme,
showing no signiﬁcant changes in the Km(MCN) and kcat and only
a slight increase in the Km(NADPH), suggesting that steady-state
enzymatic parameters alone could not account for their observed
beneﬁcial effects on growth rates.
Small Changes of in Vivo Steady-State Protein Levels Also Prove to be
Important for Increased Fitness. Fitness of cells with newly acquired
mutations in an evolving population depends not only on the
Fig. 2. Similar growth rate proﬁles for tet(X2)T280A and tet(X2)N371I suggest
that both mutants should have equal opportunity for success during selec-
tion. Shown are growth rates of the ancestral E. coli BW25113 strains
expressing a chromosomal copy of tet(X2)wild type and seven variants. The
clinical breakpoint for resistance (dashed line) to MCN is 16 μg/mL (32 μM).
At lower MCN concentrations (2 and 4 μg/mL), growth rates (e.g., ﬁtness) for
all of the variants are comparable. At higherMCN concentrations, tet(X2)T280A
and tet(X2)N371I exhibit the fastest growth rates, whereas the growth rates of
tet(X2)T280S and tet(X2)K64R are signiﬁcantly lower and resemble the growth
of wild-type tet(X2). Error bars correspond to the SD among measurements
for independent growth assays for three individual colonies.
Fig. 3. The enzymatic performance of potential adaptive
mutants from in vitro kinetics is well correlated with observed in
vivo growth rates. Very small changes in Km(MCN) for TetX2T280A
and TetX2N371I in the range of MCN concentrations used during
experimental evolution provide a successful strategy for re-
sistance. (A) Hydroxylation of MCN by TetX2 variants was moni-
tored at 12.5, 25, 50, 100, and 200 μM of NADPH at 37 °C for
5 min (TetX2T280A shown here). The initial velocities were ﬁt to
the Michaelis–Menten ping-pong mechanism equation (Eq. S1).
Error bars correspond to the standard -deviation among three
individual measurements. (B) The double-reciprocal plot of MCN
hydroxylation at various NADPH concentrations exhibits charac-
teristics of binary complex formation. Error bars correspond to
the SD among three individual measurements. Alternatively,
TetX2F235Y and TetX2T280S appear at higher in vivo steady-state
concentrations but are not able to have as much success within
bacterial populations undergoing selection. (C) Activities of
TetX2 and adaptive mutants were determined from cell lysates of
chromosomally expressed enzymes in E. coli BW25113 at 50 μM
MCN and 200 μM NADPH. Error bars correspond to standard
deviation among six independent measurements. (D) Relative
protein concentrations were determined by ﬁtting initial veloci-
ties to Eq. S1 and implementing kinetic parameters calculated in the in vitro kinetics assay. All data were normalized to the wild-type enzyme. Statistically sig-
niﬁcant differences in expression levels were observed for all mutants, compared with the wild type [using a pairwise t-test and sequential Bonferroni correction
(27)], and were most noticeable for TetX2F235Y and TetX2T280S. Error bars correspond to standard deviation among six independent measurements.







catalytic performance of a particular enzyme but also on its in vivo
expression levels. Therefore, we quantiﬁed the expression levels of
TetX2 mutants to test whether any of the variants might be present
at higher steady-state concentrations in vivo. To test this hypoth-
esis, TetX2 activity at three concentrations of MCN was measured
from cell extracts of E. coli expressing chromosomally integrated
tet(X2) variants (Fig. 3C). On the basis of the activities obtained
from cell lysates, the relative enzyme concentrations of each mu-
tant compared with those of the wild-type TetX2 were determined.
As shown in Fig. 3D, the steady-state protein levels of TetX2F235Y
and TetX2T280S are approximately twofold higher than those of the
wild type; also TetX2N371I, TetX2N371T, and TetX2S326I appear at
∼50% higher levels. The differences in the steady-state protein
levels among the mutants are consistent with the growth rate data,
which suggested that strains expressing TetX2S326I and TetX2F235Y
were better at hydrolyzing MCN than wild-type TetX2. The in
vitro kinetics together with the increased steady-state protein levels
of these two mutants are consistent with the success of strains
carrying tet(X2)S326I, tet(X2)T280S, and tet(X2)F235Y.
Adaptive TetX2 Mutants Identiﬁed and Characterized in Vitro Provide
the Basis for Quantitative ex Vivo Modeling of Fitness and Evolutionary
Dynamics. The in vitro kinetic properties of the TetX2 variants
were used to construct a mathematical model to quantitatively
describe the growth rates of each adaptive mutation over a range
of MCN concentrations (Fig. 4). Inhibition of bacterial growth
rates by cytosolic MCN was determined by ﬁtting the growth rate
dependence of E. coli to MCN to a Hill function: 1− MCNB
A+ ½MCNB
(Eq. S2). At steady state, degradation of MCN by TetX2 equals
the rate of diffusion of minocycline into the cell. The bisubstrate
kinetics formulation (Eq. S1) and Fick’s law were used to calculate
the steady-state cytosolic MCN concentration from the total
concentration of MCN (Eq. S4). The function determined by the
inhibition of MCN on growth rates of E. coli was transformed onto
the growth rates of the TetX2 variants, using the steady-state
equation (Fig. 4A), and ﬁtted using themeasured values ofKm(MCN),
Km(NADPH), and kcat. At higher concentrations of MCN, inhibition
of cell growth is a consequence of the limited ability of TetX2 or
a particular variant to inactivate MCN to tolerable levels.
Growth rates for E. coli carrying tet(X2)T280A, tet(X2)N371I,
tet(X2)N371T, and tet(X2)K64R could be predicted readily, con-
sidering largely kinetic parameters, whereas growth rates of
tet(X2)F235Y, tet(X2)S326I, and tet(X2)T280S could be predicted
reasonably only if their steady-state protein concentration was
greater than that of the wild-type TetX2 (Fig. 4). This prediction
was born out by in vivo activity measurements from cell extracts
shown in Fig. 3C. As expected from the range of selection for
MCN and bisubstrate kinetics, the ﬁt for growth rates of E. coli
with tet(X2) is most sensitive to Km for MCN and is not as sensitive
to Km for NADPH under these selection conditions (SI Materials
and Methods). The combination of Km(MCN) and kcat determines
the shape of the growth rate curves with the initial plateaus being
particularly sensitive to Km(MCN). The measured kcat values were
similar for seven of the eight variants and therefore played a lesser
role. The total activity affects the slope of the curve deﬁning how
severe the drop-off in growth rate responds to increasing MCN.
The model cannot discriminate between changes in kcat or
changes in active protein concentration because these two vari-
ables affect the shape of the growth curve in the same way. The
model underscores the strong correlation between the MCN
concentration at which the most successful adaptive mutants,
tet(X2)T280A and tet(X2)N371I, were observed by experimental
evolution (20–32 μM MCN) and their Km to MCN (Table S3).
DNA Barcoding to Quantify the Allelic Frequency of the Seven Most
Successful in Vitro tet(X2) Mutants.On the basis of growth rate and
biochemical assays, we would expect both T280A and N371I to
evolve. To test the success of mutants in evolving populations, we
evolved 10 replicate populations of BW25113tet(X2) and tracked
the rise and fall of the seven mutant alleles over the course of
3 days undergoing selection at clinically relevant MCN concen-
trations. Adaptive mutations to tet(X2) can be identiﬁed from 10
to 32 μg/mL MCN (days 1–3) during a serial transfer experiment.
Using the Illumina HiSeq sequencing system and a family of
DNA barcodes, we were able to track changes in allelic fre-
quencies for each of the characterized tet(X2) mutation sites at
a resolution sufﬁcient to identify a frequency of 0.5% with each
population (SI Materials and Methods) (16). On average, each
SNP was covered by 2.4 × 105 [95% conﬁdence interval (CI): 3.7 ×
104] reads (per population per day). As expected, tet(X2)T280A
and tet(X2)N371I had the most success and appeared in 5 and
2 populations, respectively, whereas tet(X2)K64R, tet(X2)S326I,
tet(X2)N371T, and tet(X2)F235Y were not observed. Unexpectedly,
tet(X2)T280S was observed in two populations despite data showing
that the growth rates of tet(X2)T280S were equal to those of tet(X2).
Crystal Structure of the Most Successful Adaptive TetX2 Mutant
TetX2T280A Suggests an Indirect Effect on Protein Dynamics to Increase
Enzyme Activity to MCN. To understand the role of the mutations in
the mechanism of MCN hydroxylation, we determined the crystal
structure of the most successful and kinetically efﬁcient variant,
TetX2T280A, in complex with MCN at 2.7 Å resolution (Fig. 5 and
Table S2). TetX2 is a monomer consisting of two domains, a larger
N-terminal domain harboring a Rossmann fold responsible for
interactions with the adenosine monophosphate of FAD and
a smaller C-terminal domain that surrounds the catalytic cavity of
the enzyme. The overall structure of TetX2T280A is very similar to
that of the wild-type TetX2 [rmsd = 0.34 Å; Protein Data Bank
(PDB) ID 3P9U] and 7-iodtetracycline(7-ITc):TetX2 complex
structures (rmsd = 0.24 Å; PDB ID 2Y6Q) (17). MCN was found
Fig. 4. Model incorporating in vitro enzyme kinetics and expression accu-
rately predicts growth rates and can be used to construct the physicochemical
ﬁtness landscape of TetX2. (A) A mathematical model was built to predict the
effect of TetX2 on reducing the inhibition of growth rates by MCN (SI
Materials and Methods). (B) By transforming Eq. S2 with Eq. S4 we were able
to accurately ﬁt the measured growth rate, using in vitro kinetic parameters
and estimates of protein concentration (solid line). The resulting model could
then be used to predict Km(MCN) and total enzyme activity for each of the
mutants from the measured growth rates (dashed line) for each mutant in-
dividually (Fig. S3 and Tables S3 and S4). (C) The physicochemical ﬁtness
landscape shows how changes in Km(MCN) and enzyme activity can affect
growth rates at 32 μM MCN. Predicted growth rates from measured kinetic
parameters for TetX2 (black), TetX2T280A (red), TetX2N371I (orange), TetX2N371T
(yellow), TetX2S326I (green), TetX2F235Y (blue), TetX2K64R (purple), and
TetX2T280S (magenta) are highlighted on the surface of the ﬁtness landscape.
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in a similar conformation in the active site to 7-ITc with the hy-
drophilic portion of the substrate oriented toward the isoalloxazine
ring of FAD (17). The structure clearly shows that position 280 is
not directly involved in the catalytic mechanism of the enzyme and
suggests that TetX2T280A alters kinetics indirectly perhaps through
altered protein dynamics (SI Materials and Methods and Fig. S4).
Mapping of the other adaptive TetX2 mutations onto the
crystal structure of the TetX2T280A:MCN complex (Fig. 5)
showed that all of the mutated residues, except TetX2K64R and
TetX2S326I, are located on the second domain of the protein,
which is implicated largely in substrate recognition. Only resi-
dues at positions 235 and 371 are within 5 Å of MCN (Fig. 5A).
The side chain of Phe235 is oriented 180° away from the sub-
strate and makes van der Waal contacts within a hydrophobic
pocket (Fig. 5C) but the polar hydroxyl group of Tyr235 in
TetX2F235Y could readily satisfy a new hydrogen bond to Thr281,
potentially stabilizing the protein. In contrast to position 235, the
side chain of Asn371 is oriented directly toward the D-ring of
MCN (∼4.7 Å) (Fig. 5A) at the putative entrance site for tetra-
cyclines. Substitution of a nonpolar residue (Ile) or a shorter polar
side chain (Thr) at position 371 near the apolar pocket (Fig. 5B)
results in smaller Km(MCN) and modest increases in kcat. These
ﬁndings clearly demonstrate that even mutations outside of the
active site can have large effects on the ﬁtness of the organisms.
Discussion
The molecular pathways accessible in protein evolution are de-
ﬁned by the mutation supply and the ﬁtness effects of these
mutations in the selective environment. In this study, we tested
the hypothesis that on the basis of in vitro physicochemical
properties of potential TetX2 adaptive mutants we could build
a mathematical model that accurately predicts changes to ﬁtness
from biochemical ﬁrst principles. In practice, this model is entirely
reversible and permits the evaluation of speciﬁc changes to ki-
netic performance such as Km, enzyme expression, and Vmax from
the growth rates of cells measured at varying substrate concen-
trations. Development of an accurate model relating growth
rates to enzyme performance would also allow quantitative high-
throughput screening of large libraries of enzyme variants without
the need for arduous protein puriﬁcation, facilitating investiga-
tion of enzyme adaptation in a highly systematic fashion (Fig. S4
and Table S3).
We chose the tetracycline-resistant enzyme, TetX2, as a model
system to study the biophysical basis for adaptation to antibiotics.
We identiﬁed a family of TetX2 variants and showed that growth
rates of E. coli expressing chromosomal copies of the tet(X2)
mutant alleles were exquisitely sensitive to MCN concentration
and were tightly correlated to catalytic performance and steady-
state expression levels of the TetX2 variants. On the basis of
these experimental results, we were able to construct a mathe-
matical model that consolidated the classic Michaelis–Menten
kinetics and the relative in vivo expression levels to accurately
and quantitatively predict growth rates and population dynamics.
Our work shows that small changes in kinetic parameters and
steady-state protein concentrations can have large consequences
on organismal ﬁtness and adds to the repertoire of mechanisms
through which drug resistance evolves. The success of TetX2
mutants with small improvements in catalytic performance over
the wild-type TetX2 was reﬂected by large ﬁtness beneﬁts con-
ferred by these variants in vivo as shown by growth rate assays
(Table 1 and Fig. 2). We observed that the three mutants with
the fastest growth rates at intermediate drug concentrations,
TetX2T280A, TetX2N371I, and TetX2N371T produced at most
a twofold decrease in Km(MCN) and, at most, a slight increase in
kcat. Even though the Km for NADPH varied more widely among
these three mutants, the in vivo concentration of NADPH is 5–10
times higher than that of MCN, making TetX2 performance less
dependent on the concentration of NADPH under these selection
conditions (18). A similar trend was observed for the mutant
TetX2K64R, which had growth rates and kinetics comparable to
those of wild-type TetX2. The in vivo performance of TetX2F235Y
and TetX2T280S was linked to at most twofold changes in steady-
state protein levels, again emphasizing the relevance of small
changes in activity over the relevant range of selection to ﬁtness.
These combined effects on ﬁtness are readily evident when overall
activity is plotted as a function of Km(MCN) and kcat[TetX2] to build
a physicochemical ﬁtness landscape for TetX2 (Fig. 4B).
Why might small steps in enzyme performance be more
common during selection? First, mutations that result in only
modest changes to enzyme performance are more common than
those with large changes (19, 20). As shown by our results, even
very modest changes in physicochemical performance can have
very strong ﬁtness effects, depending on the context of selection.
As long as a mutation alters protein performance sufﬁciently to
meet the physiological needs of the cell, there is no necessary
advantage to an enzyme that is “better” in terms of in vitro
performance than others (21, 22). In addition, as beneﬁcial
mutations accumulate there is a general trend toward negative
epistasis that shapes the adaptive landscape (1, 23).
Second, mutational spectra can change with the inherent DNA
replication, recombination, and repair efﬁciencies of an organism
as well as with the manner in which selection conditions induce
stress (24, 25). Whereas we often envision selection as a harsh
ﬁlter on populations, niche invasion can be a more gradual series
of events wherein cells can work at the periphery of a condition,
using the smaller, more numerous, and therefore more accessible
ensemble of molecular trajectories afforded by protein structure
and function. Although there has been much interest in changes
to enzyme function that dramatically alter kinetic parameters, it is
more likely that much more modest changes in enzyme perfor-
mance may represent the more common adaptive pathway.
Our work shows that on the basis of molecular properties of the
adaptive mutants of TetX2, we can accurately predict the success
of mutant alleles during adaptation to antibiotic. As shown in Fig.
S5, serial passages of 10 populations showed that in vitro enzyme
kinetics correctly predicted the most successful adaptive alleles
tet(X2)T280A and tet(X2)N371I. Of the 7 populations where adaptive
mutations to tet(X2) were observed, 5 contained tet(X2)T280A and
tet(X2)N371I whereas 2 showed the presence of an allele that would
be close to neutral, tet(X2)T280S. The remaining four tet(X2) alleles
Fig. 5. Structure of the most efﬁcient variant, TetX2T280A, in complex withMCN
at 2.7 Å resolution. (A) Ribbon representation of TetX2T280A structure with MCN
shown in yellow and FAD in orange as sticks. The position of each adaptive point
mutation is indicated as a sphere: 280 (red), 371 (orange), 326 (green), 235 (blue),
and 64 (purple). (B) Active site of TetX2T280A illustrating residues interacting with
MCN with 2Fo-Fc SIGMAA-weighted electron density map contoured at 1σ. (C)
View of the active site with conserved nonpolar residues shown in purple.







predicted to have little or no success according to the in vitro data
did not appear at our level of detection (≥0.5% of the overall
population). Although it is possible that tet(X2)T280S may have an
as yet unidentiﬁed ﬁtness beneﬁt, this was not observed in growth
rate of the chromosomally expressed gene, enzyme kinetics of
the puriﬁed enzyme, MIC determination from the chromosomal
clone, or assays of crude extracts. The unexpected success of
tet(X2)T280S is a cautionary tale and may support an important role
for mutation supply, clonal interference, and epistasis in evolu-
tionary dynamics (6, 7). Taken together, these studies show that
physicochemical and structural properties of enzymes can be used
to construct a quantitative prediction of ﬁtness that can be used in
conjunction with experimental evolution to explore the role of
even the most modest changes in physical properties to large
consequences to organismal ﬁtness during natural selection.
Materials and Methods
Library Construction. Tet(X2) mutants were made using error-prone PCR
following the manufacturer’s protocols (GeneMorphII Random Mutagenesis
Kit; Agilent Technologies). An appropriate tet(X2) library with one to two
mutations per reaction was generated and subcloned into pUC19 (Invi-
trogen) to generate tet(X2)/pUC19 vector (SI Materials and Methods).
Tet(X2) mutants that conferred the same or higher MIC relative to wild-type
tet(X2) were isolated by plating at 4 μg/mL of MCN. DNA sequencing of
35 colonies identiﬁed seven tet(X2) mutants: tet(X2)T280A, tet(X2)N371I,
tet(X2)N371T, tet(X2)F235Y, tet(X2)S326I, tet(X2)T280S, and tet(X2)K64R.
Construction of Recombinant Strains. Integration of tet(X2) or variants into
the chromosome of E. coli strain BW25113 was performed using a short
homology recombineering approach (12). Brieﬂy, tet(X2)was ampliﬁed from
tet(X2)/pUC19 and used as a template for recombination into the spc operon
of E. coli between prlA (SecY) and rmpJ (L36) to generate BW25113tet(X2) (SI
Materials and Methods).
Growth Assays. Growth assays were performed in a 96-well plate format, using
the Synergy 2 Multi-Mode Microplate Reader (BioTek Instruments). Single colo-
nies of E. coli carrying different tet(X2) variants were used to inoculate overnight
cultures and subsequently diluted to a ﬁnal OD600 of 0.01. Growth at OD600 was
monitored in 5-min intervals over 24 h at MCN concentrations ranging from 0 to
50 μg/mL. The fastest growth was deﬁned as a slope of a tangent parallel to
linear log-phase growth (SI Materials and Methods and Fig. S2).
Protein Expression and Puriﬁcation. All proteins were overexpressed in E. coli
BL21(DE3) Star (Agilent Technologies) with cleavable N-terminal 6×Histag
and puriﬁed as described previously (SI Materials and Methods) (26).
Kinetic Studies. Steady-state kinetic parameters were measured using a pre-
viously described, but modiﬁed TetX2 activity assay (14) (SI Materials and
Methods). Steady-state kinetic parameters were determined by ﬁtting initial
reaction rates (υ0) to a ping-pong mechanism (Eq. S1).
TetX2 Activity from Cell Extracts. In vivo TetX2-mediated inactivation of MCN
was estimated from cell extracts prepared from each of the E. coli BW25113 cell
lines expressing chromosomal copies of wild-type and mutant tet(X2). Back-
ground levels of MCN inactivation activity were determined from extracts of
BW25113 without tet(X2). Cells were grown in lysogeny broth (LB) without
MCN at 37 °C and harvested by centrifugation at an OD ∼ 0.6–0.8 before lysis
by sonication. The steady-state TetX2 activity for inactivation of MCN by the
soluble crude extracts was assayed using the previously described in vitro assay.
TetX2 activity was measured at 25, 50, and 200 μMMCN at 200 μM of NADPH.
All measurements were done in triplicate. The total amount of protein in each
cell lysate was estimated by Bradford assay to account for variability in the
efﬁciency of cell lysis. Relative enzyme concentrations were calculated from
Eq. S1, where Vmax = kcat[E0], and E0 = total enzyme concentration.
Structure Determination and Reﬁnement. Crystallization of TetX2T280A was
performed under similar conditions to those of the wild-type TetX2 (26). The
structure was solved by molecular replacement, using 3P9U as a search
model (SI Materials and Methods). The structure coordinates and amplitudes
were deposited as 3V3N.
Serial-Passage Evolution Experiment. TheMIC of E. coli BW25113tet(X2) in liquid
culturewas determined to be 16 μg/mLMCN in LB at 37 °C. To determinewhen
changes to tet(X2) could be observed, serial passage experiments were initi-
ated at 10 μg/mL MCN and increased daily as 10, 16, 24, 36, 52, 80, 120, 180,
300, and 320 μg/mL MCN. DNA samples for deep sequencing of 10 in-
dependent replicates was obtained from populations at 10, 16, and 24 μg/mL
MCN. Each day 50 μL of the populationwas transferred to a new condition and
1-mL samples were frozen at−80 °C for DNA sequencing and characterization.
DNA Barcoding.We received 81 barcode plasmids containing distinct barcode
sequences as a gift from the Marx Laboratory at Harvard University (Cam-
bridge, MA) (16) (SI Materials and Methods).
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